- An overview of ACS, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.- Annualized APAC ACS in vitro diagnostic testing reagents market revenue and future forecasts from 2009 to 2011, forecast for 7 years to 2018.- Investigation of current and future market competition for diagnostic cardiac biomarkers for ACS- Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events.- Competitor assessment including device approval analysis and device sales forecasts.- Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast.- Analysis of unmet needs within the market and opportunities for future players.- Technology trends evaluation to assess strength of pipeline.- An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines.- Company profiles including business description, financial overview and SWOT analysis.- Coverage of key market players.- Strategic assessment of the diagnostic cardiac biomarkers for ACS sector through market impact analysis, future market scenario and company analysis.- Direct quotes from Key Opinion Leaders (KOL) as well as cardiologists
Reasons to buy
- Understand the trends shaping and driving APAC diagnostic cardiac biomarkers for ACS.- Realize device preferences of physicians who have performed the tests already.- Access market sizing, forecasts and quantified growth opportunities in APAC diagnostic cardiac biomarkers for ACS Market through 2018.- Quantify candidate patient populations to better design product pricing & launch plans.- Drive revenues, formulate effective sales and marketing strategies and gain in-depth understandin
Copyright©2012 PR Newswire.
All rights reserved